CTLA4 and neoplasm: A similar approach was used by the group of Thakkar et al., whose 17-residue cyclic peptide (P16, Table 1) binds to CTLA-4 with a strength of 31 μM and inhibits tumor growth in a co-culture of Lewis lung carcinoma.